Drug-Eluting Portfolio Video
See how Boston Scientific is committed to advancing science in the fight against PAD by boldly innovating with next-generation, drug-eluting technology.
Drug-Eluting Investment in Clinical Data
The best outcomes begin with our investment in the quality and quantity of evidence you demand.
Ravish Sachar, MD shares perspectives on Boston Scientific’s Drug-Eluting Technologies.
Ranger™ Drug-Coated Balloon
DE Clinical Data Animation - RANGER II SFA
View the 2-year primary patency results from the RANGER II SFA RCT.
COMPARE randomized Controlled Trial Results
View the COMPARE Clinical Trial 2-Year results.
Eluvia™ Drug-Eluting Vascular Stent System
DE Clinical Data Animation - EMINENT
View the 1-year primary patency results from the world's largest RCT of SFA stents: Eluvia DES vs. BMS.
See what physicians are saying about the unprecedented clinical outcomes for the Eluvia Drug-Eluting Stent, including two-year primary patency and TLR rates.
Hear what physicians have to say about the challenges of treating the SFA and how drug-eluting stents may help improve patient outcomes.
See how over a decade of research helped Eluvia DES engineers develop the first drug-eluting stent for the SFA designed to sustain drug release when restenosis is most likely.
Physicians talk about the importance of drug-eluting stents in complex lesions and how the Eluvia Drug-Eluting Stent is fine-tuned to produce a sustainable release of paclitaxel over time.
The Challenges of the SFA
Find out how the challenging biological environment, mechanical issues and timing of disease progression impact treatment of the SFA.
IMPERIAL Trial: First of its Kind Design
Physicians provide an overview of the trial’s unique design, including the Eluvia DES and how investigators sought to improve on prior technologies.
Impact of the IMPERIAL Trial
Hear physician commentary on how the IMPERIAL Trial’s level 1 evidence is influencing their clinical and economic decisions.
IMPERIAL Trial: Influencing Treatment Algorithms
See how IMPERIAL Trial results may help physicians make recommendations on which forms of antiproliferative therapies are best for each patient.
The Design of the Eluvia Drug-Eluting Stent System
Discover how the Eluvia Drug-Eluting Stent was designed to match the restenotic cascade for better healing and patency in the superficial femoral arteries (SFA).
Explore DE Resources
Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.
Stay Up to Date
Receive emails about the latest drug-eluting technology news, innovations and events in your area.